127 related articles for article (PubMed ID: 32010933)
1. GCdiscrimination: identification of gastric cancer based on a milliliter of blood.
Wu J; Yang Y; Cheng L; Wu J; Xi L; Ma Y; Zhang P; Xu X; Zhang D; Li S
Brief Bioinform; 2021 Jan; 22(1):536-544. PubMed ID: 32010933
[TBL] [Abstract][Full Text] [Related]
2. Intelligent identification system of gastric stromal tumors based on blood biopsy indicators.
Han S; Song M; Wang J; Huang Y; Li Z; Yang A; Sui C; Zhang Z; Qiao J; Yang J
BMC Med Inform Decis Mak; 2023 Oct; 23(1):214. PubMed ID: 37833709
[TBL] [Abstract][Full Text] [Related]
3. ATBdiscrimination: An in Silico Tool for Identification of Active Tuberculosis Disease Based on Routine Blood Test and T-SPOT.TB Detection Results.
Wu J; Bai J; Wang W; Xi L; Zhang P; Lan J; Zhang L; Li S
J Chem Inf Model; 2019 Nov; 59(11):4561-4568. PubMed ID: 31609612
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Power of Blood Parameters as Screening Markers in Gastric Cancer Patients.
Pietrzyk L; Plewa Z; Denisow-Pietrzyk M; Zebrowski R; Torres K
Asian Pac J Cancer Prev; 2016; 17(9):4433-4437. PubMed ID: 27797257
[TBL] [Abstract][Full Text] [Related]
5. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer.
Cheng S; Han F; Wang Y; Xu Y; Qu T; Ju Y; Lu Z
BMC Gastroenterol; 2017 Dec; 17(1):163. PubMed ID: 29262773
[TBL] [Abstract][Full Text] [Related]
6. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
7. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
8. Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.
Tsai MM; Wang CS; Tsai CY; Chi HC; Tseng YH; Lin KH
World J Gastroenterol; 2014 Oct; 20(38):13791-803. PubMed ID: 25320517
[TBL] [Abstract][Full Text] [Related]
9. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.
Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC
Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
[TBL] [Abstract][Full Text] [Related]
13. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
14. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
15. Liq_ccRCC: Identification of Clear Cell Renal Cell Carcinoma Based on the Integration of Clinical Liquid Indices.
Zhao J; Wu J; Wei J; Su X; Chai Y; Li S; Wang Z
Front Oncol; 2020; 10():605769. PubMed ID: 33585225
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer.
Chen J; Liu Z; Gao G; Mo Y; Zhou H; Huang W; Wu L; He X; Ding J; Luo C; Long H; Feng J; Sun Y; Guan X
Oncol Lett; 2021 Oct; 22(4):725. PubMed ID: 34429765
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers.
Wu CH; Lin SR; Yu FJ; Wu DC; Pan YS; Hsieh JS; Huang SY; Wang JY
Int J Cancer; 2006 Jul; 119(2):373-9. PubMed ID: 16477642
[TBL] [Abstract][Full Text] [Related]
18. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
19. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.
Wang H; Wang L; Wu Z; Sun R; Jin H; Ma J; Liu L; Ling R; Yi J; Wang L; Bian J; Chen J; Li N; Yuan S; Yun J
Med Oncol; 2014 Dec; 31(12):298. PubMed ID: 25367852
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
